OrbiMed’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $22.1M | Sell |
|
|||||
2024
Q4 | $22.7M | Buy |
|
|||||
2024
Q3 | $12.7M | Buy |
|
|||||
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $8.1M | Hold |
|
|||||
2023
Q3 | $7.49M | Hold |
|
|||||
2023
Q2 | $7.71M | Buy |
|
|||||
2022
Q3 | – | Sell |
|
|||||
2022
Q2 | $17.8K | Hold |
|
|||||
2022
Q1 | $17.1M | Hold |
|
|||||
2021
Q4 | $20.9M | Hold |
|
|||||
2021
Q3 | $20.1M | Hold |
|
|||||
2021
Q2 | $19.8M | Hold |
|
|||||
2021
Q1 | $18.6M | Buy |
|
|||||
2020
Q4 | $11.2M | Hold |
|
|||||
2020
Q3 | $12.1M | Hold |
|
|||||
2020
Q2 | $14.8M | Sell |
|
|||||
2020
Q1 | $110M | Buy |
|
|||||
2019
Q4 | $21.2M | Hold |
|
|||||
2019
Q3 | $20.7M | Sell |
|
|||||
2019
Q2 | $27.1M | Sell |
|
|||||
2019
Q1 | $28.9M | Hold |
|
|||||
2018
Q4 | $27.8M | Buy |
|
|||||
2018
Q3 | $28.2M | Hold |
|
|||||
2018
Q2 | $25.8M | Hold |
|
|||||
2018
Q1 | $27.5M | Sell |
|
|||||
2017
Q4 | $37.4M | Sell |
|
|||||
2017
Q3 | $156M | Sell |
|
|||||
2017
Q2 | $147M | Buy |
|
|||||
2017
Q1 | $54.4M | Sell |
|
|||||
2016
Q4 | $75.6M | Sell |
|
|||||
2016
Q3 | $159M | Sell |
|
|||||
2016
Q2 | $256M | Buy |
|
|||||
2016
Q1 | $277M | Sell |
|
|||||
2015
Q4 | $346M | Buy |
|
|||||
2015
Q3 | $214M | Sell |
|
|||||
2015
Q2 | $339M | Sell |
|
|||||
2015
Q1 | $335M | Sell |
|
|||||
2014
Q4 | $401M | Buy |
|
|||||
2014
Q3 | $400M | Buy |
|
|||||
2014
Q2 | $285M | Sell |
|
|||||
2014
Q1 | $377M | Buy |
|
|||||
2013
Q4 | $375M | Buy |
|
|||||
2013
Q3 | $300M | Sell |
|
|||||
2013
Q2 | $247M | Buy |
|